Last reviewed · How we verify
NCT07049900
Baby ABS (Abdominal Binder Study)
NA trial testing NeoBelly Band in Premature in 40 participants. Currently enrolling.
30 September 2026
Quick facts
| Lead sponsor | University of Minnesota |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 22 September 2025 |
| Primary completion | 30 September 2026 |
| Estimated completion | 28 February 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- NeoBelly Band
Conditions studied
- Premature — all drugs for Premature →
- Premature Lungs — all drugs for Premature Lungs →
- Ventilator Lung; Newborn — all drugs for Ventilator Lung; Newborn →
- Rectus Abdominis — all drugs for Rectus Abdominis →
Sponsor
University of Minnesota
Who can join
Adults 26 Weeks to 31 Weeks, any sex, with Premature or Premature Lungs. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier corrected gestational age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07049900
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premature
Currently open trials in the same condition.
- NCT07371845 — Effect of Teach-Back Education on Breastfeeding and Bonding in Mothers of Preterm Infants · NA · recruiting
- NCT07154186 — Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients · recruiting
- NCT07088302 — Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates · NA · recruiting
- NCT06812507 — Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their He · NA · recruiting
- NCT06672913 — Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study · NA · recruiting
Other University of Minnesota trials
Trials by the same sponsor.
- NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
- NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
- NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07049900 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
- Last refreshed: 26 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07049900.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing